September 11, 2021
A new study has shown that the tumour-inhibiting gene TET2 is silenced in a large fraction of cases of acute lymphoblastic leukemia (ALL) in children. The scientists show that the gene can be reactivated by an existing drug, 5-azacytidine. The results suggest that 5-azacytidine may function as targeted therapy for […]